Last updated: April 23, 2026
RASUVO (methotrexate) Suppliers: What the Public Record Shows
RASUVO is a methotrexate injection marketed by Hikma Pharmaceuticals USA (brand ownership/labeling entity). Publicly available records for “RASUVO suppliers” typically resolve to (1) the labeler/marketing authorization holder and (2) CMOs and raw-material suppliers behind the scenes; the latter are not consistently disclosed in open sources.
Who is the supplier for RASUVO in public labeling and regulatory materials?
Labeler / marketing authorization holder (primary “supplier” in regulatory distribution terms):
- Hikma Pharmaceuticals USA (RASUVO NDA labeler entity)
What else is visible in open sources beyond the labeler?
Open regulatory and commercial sources generally do not provide a complete, citable list of:
- finished-dose contract manufacturers (CMOs)
- sterile fill-finish sites for each strength/form
- API suppliers for methotrexate used in RASUVO
- device and packaging component suppliers for the autoinjector system
For RASUVO specifically, the public record that can be cited cleanly is the labeling/marketing entity, not a full supply chain map.
RASUVO brand ownership: labeler details
| Item |
Publicly stated entity for RASUVO |
| Product labeler / marketer |
Hikma Pharmaceuticals USA |
Key Takeaways
- Hikma Pharmaceuticals USA is the identifiable supplier/labeler for RASUVO in public regulatory and labeling sources.
- A fully sourced list of API and CMO suppliers for RASUVO is not consistently disclosed in open, citable records.
FAQs
1) Who makes RASUVO?
The public labeler/marketing entity for RASUVO is Hikma Pharmaceuticals USA.
2) Are methotrexate API suppliers for RASUVO disclosed publicly?
Not in a complete, reliably citable way in standard open regulatory sources for this product.
3) Who performs sterile fill-finish for RASUVO?
The fill-finish contractor is not consistently disclosed in public sources for RASUVO in a way that supports a supplier list.
4) Are device and packaging suppliers for RASUVO disclosed publicly?
Not in a complete, citable way in standard open regulatory sources for this product.
5) What is the only supplier definition that can be stated with citation-level support here?
The labeler/marketing authorization holder.
References
[1] U.S. Food and Drug Administration. RASUVO (methotrexate) injection. Drug label and product information (labeler/marketing authorization holder). https://www.accessdata.fda.gov/ (search “RASUVO methotrexate injection labeler Hikma Pharmaceuticals USA”).
